Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.5997
-0.0046 (-0.76%)
At close: Oct 31, 2025, 4:00 PM EDT
0.6000
+0.0003 (0.05%)
After-hours: Oct 31, 2025, 7:57 PM EDT
RVPH Market Cap
RVPH has a market cap or net worth of $57.77 million as of October 31, 2025. Its market cap has increased by 41.93% in one year.
Market Cap
57.77M
Enterprise Value
47.52M
1-Year Change
41.93%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $57.77M, an increase of 129.17%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 56.55M | -32.92% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 236.67B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |